14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61422 |
DPP-4-IN-1
|
||
DPP-4-IN-1 (compound d1) is a highly potent inhibitor of DPP-4 (dipeptidyl peptidase 4) with an IC 50 of 49 nM, making it suitable for diabetes research [1]. It shares structural similarities to Alogliptin and can be effectively utilized for studying diabetes-related mechanisms. | |||
T6999 |
Teneligliptin hydrobromide
Teneligliptin hydrobromide anhydrous,MP-513 (hydrobromide) |
Others; Proteasome; DPP-4 | Others; Proteases/Proteasome; Ubiquitination |
Teneligliptin hydrobromide (MP-513(hydrobromide)) 是β2肾上腺素能受体 (β2AR) 阻滞剂,具有抗高血压、抗氧化、清除自由基的活性。 | |||
T0242 |
Sitagliptin
西他列汀,MK0431,西格列汀 |
Proteasome; DPP-4; Autophagy | Autophagy; Proteases/Proteasome; Ubiquitination |
Sitagliptin (MK0431) 是一种有效的 DPP4抑制剂,在 Caco-2 细胞中,IC50值为 19 nM。它是一种新型口服降糖药,可单独使用或与二甲双胍或噻唑烷二酮联合用于治疗 2 型糖尿病。 | |||
T61018 |
DPP-4-IN-2
|
||
DPP-4-IN-2 (compound b2) 是 Alogliptin 的结构类似物,可以用于研究糖尿病。DPP-4-IN-2 是二肽基肽酶 4 (DPP-4)的有效抑制剂,IC50值为 79 nM。 | |||
T41250 |
Teneligliptin hydrobromide hydrate
|
||
Teneligliptin hydrobromide hydrate 是一种有效的 DPP-4抑制剂,可在体外竞争性抑制人血浆、大鼠血浆和重组人 DPP-4 ,IC50值约为 1 nM。 | |||
T74592 |
Sitagliptin fenilalanil hydrochloride
|
||
Sitagliptin fenilalanil hydrochloride 是一种二肽氨基肽酶 (DPP-4) 抑制剂。 | |||
T74528 |
DPP-4/GPR119 modulator 1
|
||
DPP-4/GPR119 modulator 1 (Compound 22) 是一种具有口服活性的二肽基肽酶 IV (DPP-IV) 抑制剂和 GPR119激动剂。DPP-4/GPR119 modulator 1 具有降血糖作用,抑制hERG 通道,IC50值为 4.9 µM。DPP-4/GPR119 modulator 1 可用于糖尿病的研究。 | |||
T76922 | Begelomab | ||
Begelomab (SAND-26) 是一种针对 DPP-4/CD26的鼠IgG2b 单克隆抗体。 Begelomab 可用于严重难治性特发性炎症性肌病的研究。 | |||
T37522 | Teneligliptin | ||
Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. Teneligliptin (MP-513) inhibits all these DPP-4 enzymes in a concentration-dependent manner. The IC50s of Teneligliptin (MP-513) for rhDPP-4, human plasma, and rat plasma are 0.889, 1.75, and 1.35 nM, respectively. A study of enzyme inhibition kinetics is conducted for Teneligliptin (M... | |||
T73875 |
Fotagliptin benzoate
|
||
Fotagliptin benzoate,作为一种二肽基肽酶IV (DPP-4) 抑制剂(IC50=2.27 nM),在大鼠和狗中展现了安全性,适用于2型糖尿病的研究。 | |||
T79256 |
DPP-4-IN-8
|
||
DPP-4-IN-8 (compound 27) 是一种高效的选择性DPP4抑制剂,具有 0.96 μM 的 Ki。该化合物能够抑制 Caco-2 和 HepG-2 细胞中的 DPP4 二肽酶活性,并剂量依赖性地降低 TNF-α、IL-6 和 IL-1β 的表达水平[1]。 | |||
T78571 |
Albiglutide fragment TFA
GLP-1-Gly8 TFA,GLP-1 (7-36) analog TFA |
||
Albiglutide fragment (GLP-1 (7-36) analog) TFA为Albiglutide活性片段,代表胰高血糖素样肽-1(GLP-1)模拟物,属长效GLP-1受体激动剂。由GLP-1二聚体抗DPP-4特性与人白蛋白基因融合而成,本化合物在降低糖化血红蛋白(A1C)方面表现显著,主要应用于2型糖尿病(T2D)的相关研究。 | |||
T37861 |
Talabostat
|
||
Talabostat (PT100, Val-boroPro) is a potent, nonselective and orally available dipeptidyl peptidase IV (DPP-IV) inhibitor with a Ki of 0.18 nM. Talabostat is a nonselective DPP-IV inhibitor, inhibiting DPP8/9, FAP, DPP2 and some other DASH family enzymes essentially as potently as it inhibits DPP-IV[1]. Talabostat stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. The inhibition of two serine proteases, DPP8 and DPP9,... | |||
T35599 |
Neuropeptide Y (3-36) (human, rat) (trifluoroacetate salt)
|
||
Neuropeptide Y (NPY) (3-36) is a C-terminal fragment of NPY, a neuropeptide involved in controlling appetite, blood pressure, cardiac contractility, and intestinal secretion. NPY (3-36) is an endogenous peptide produced by cleavage of NPY by dipeptidyl peptidase 4 (DPP-4). It binds selectively to the NPY receptor Y2 (Ki = 0.41 nM in CHP 234 cells) over the Y1 receptor, where it does not bind at concentrations up to 1 μM. NPY (3-36) (0.1 nM) increases migration of human umbilical vein endothelial... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T81898 |
Lyciumamide A
|
||
DPP-IV-IN-5,一种从枸杞果实中分离得到的化合物,对过氧化物酶体增殖物激活受体(PPARγ)展示中等拮抗活性,其EC50值介于10.09至44.26 μM,同时对二肽基肽酶-4 (DPPIV)亦有抑制作用,IC50值为47.13 μM。 |